WEX (WEX) announced that it filed definitive proxy materials with the Securities and Exchange Commission in connection with its upcoming 2026 Annual Meeting of Stockholders, scheduled for May 5, 2026. In conjunction with the definitive proxy materials, WEX is also mailing a letter to shareholders. Highlights from the letter include: WEX’s strategy is delivering improved results. In 2025, WEX delivered record revenue and made significant progress on important strategic initiatives, increasing the pace of product innovation by more than 50%. WEX’s Board has been executing a multi-year refreshment program. Since 2020, eight directors have retired or are not standing for reelection at the Annual Meeting, and six new directors have been appointed to ensure the Board maintains the right balance of skills, experience and perspectives. WEX has engaged extensively with Impactive and sought a constructive resolution. The Company has held dozens of meetings over multiple years and offered to appoint two of
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WEX:
- Wex launches Health Reimbursement Arrangement for GLP-1 medications
- WEX Inc. Confronts Activist Pressure as Impactive Capital Launches Costly Proxy Fight
- Impactive Capital nominates four candidates to Wex board
- WEX Inc. Earnings Call Highlights Growth Amid Headwinds
- Wex price target raised to $146 from $144 at Morgan Stanley
